Uuenda hematoloogia / onkoloogia konverentsi

VÄRSKENDUS Hämatologie / Onkologie 2021

Värskendage hematoloogiat / onkoloogiat 2024. Jätkake programmiga. Jätkake sponsorite ja eksponentide teabega. Jätkake registreerimisega. Telli meie uudiskiri siin! Covid-19 meetmed Hamburgis osalemiseks Oleme siin, et aidata! Radisson Blu Hotel Hamburg. Värskendus 2023. Värskenda hematoloogia ja onkoloogia virtuaalset. Ole esimene, kes osaleb.100%Virtuaalne UUENDUS hematoloogias/onkoloogias

A concept of hygiene for the Congress is not yet clear due to the dynamic pandemic. We will put in place a plan that is appropriate for the situation as soon as it becomes foreseeable. We will notify you of any possible measures in advance.

Üldise hügieeni kohta lisateabe saamiseks klõpsake alloleval nupul.

GSK on rahvusvaheline tervishoiuliider, mis keskendub teadusuuringutele. Selle missiooniks on parandada inimeste elukvaliteeti, aidates neil elada tervislikumalt, kauem ja aktiivsemalt. Meie eesmärk on olla üks võimsamaid, innovaatilisemaid ja usaldusväärsemaid tervishoiuettevõtteid maailmas.

GSK is a pioneer in the field of prevention with its comprehensive portfolios of respiratory therapies and vaccines. ViiV Healthcare, our subsidiary, is also active in HIV. We are also one of the leading manufacturers of consumer healthcare products. Our research and developments are focused on immune science, genetics, and advanced technologies. Our current focus is on developing new drugs in the areas related to respiratory diseases and HIV/infectious disease, oncology, and inflammatory immune disorders.